Pyoderma gangrenosum in myelodysplasia responding to granulocyte macrophage-colony stimulating factor (GM-CSF) [7]

British Journal of Dermatology

Volumn 136, Issue 4, 1997, Pages 637-638

  Bulvik, S ^a   Jacobs, P ^a  

^a LANIADO HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MERCAPTOPURINE;

ADULT; CASE REPORT; HUMAN; LETTER; MALE; MYELODYSPLASIA; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030965537     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb02169.x     Document Type: Letter

References (13)

1. 1 Duguid CM. Powell EC, Pyoderma gangrenosum. Clin Dermatol 1993 ; 11: 129–33.
2. 2 Ho KK. Otridge BW, Van Denberg E. Powell FC, Pyoderma gangrenosum, polycythemia rubra vera, and the development of leukemia. J Am Acad Dermatol 1992 ; 27: 804–8.
3. 3 Paolini O. Hebuterne X. Flory P et al. Treatment of pyoderma gangrenosum with colchicines. Lancet 1995 ; 345: 1057–8.
4. 4 Gupta AK, Shear NH. Sauder DN. Efficacy of human intravenous immune globulin in pyoderma gangrenosum. J Am Acad Dermatol ; 32: 140–2.
5. 5 Hughes JR. Smith E. Higgins EM et al. Pyoderma gangrenosum in a patient with rheumatoid arthritis respinding to treatment with cyclosporin A. Br J Rheumatol 1994 ; 33: 680–1.
6. 6 Elgart G. Stover P. Larson K et al. Treatment of pyoderma gangrenosum with cyclosporine: results in seven patients. J Am Acad Dermatol 1991 ; 24: 83–6.
7. 7 Abu‐Elmagd K. Van Thiel DH, Jegasothy BY et al. Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). Am Intern Med 1993 ; 119: 595–8.
8. 8 Callen JP. Pyoderma gangrenosum and related disorders. Med Clin North Am 1989 ; 73: 1247–61.
9. 9 Jacobs P. Palmer S. Gordon‐Smith EC. Pyoderma gangrenosum in myelodysplasia and acute leukaemia. Postgrad Med J 1985 ; 61: 689–94.
10. 10 Bentley‐Phillips CB, Cooper RC, Hallett AF. Pharmacological modulation of neutrophil phagocytic function in a patient with recurrent sepsis, pyoderma gangrenosum and impaired phagocytosis. Br J Dermatol 1982 ; 106: 687–95.
11. 11 Verhoef G. Boogaerts M. In vivo administration of granulocytemacrophage colony stimulating factor enhances neutrophil function in patients with myelodysplastic syndromes. Br J Haematol 1991 ; 79: 177–84.
12. 12 Johnson ML. Grimwood RE. Leukocyte colony‐stimulating factors a review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol 1994 ; 130: 77–81.
13. 13 Perrot JL, Benoit F. administration de GM‐CSF. Ann Dermatol Venereol 1992 ; 119: 846–8.